Bacterial vaginosis (BV) is diagnosed through a combination of symptoms, a physical exam, and lab tests that check your vaginal pH, discharge, and the types of bacteria present. There’s no single test that confirms it on its own. Instead, your healthcare provider looks at several markers together to distinguish BV from other common vaginal infections like yeast infections or trichomoniasis.
What Happens During the Exam
A BV evaluation starts with a vaginal swab. Your provider collects a sample from the vaginal wall, inserting a swab about two inches and rotating it gently for 10 to 30 seconds to absorb moisture. This sample is then used for several different tests, sometimes right in the office and sometimes sent to a lab. The whole process is quick and no more uncomfortable than a routine pelvic exam.
The Four Clinical Criteria
The most widely used in-office method checks four things, known as the Amsel criteria. You need at least three of the four to be positive for a BV diagnosis:
- Thin, homogeneous discharge: BV produces a grayish-white discharge that looks uniform rather than clumpy. It coats the vaginal walls evenly.
- Vaginal pH above 4.5: A healthy vagina typically sits between 3.8 and 4.5 on the pH scale. BV shifts the environment to be less acidic, pushing the pH higher. Your provider checks this by touching pH paper to the vaginal wall or to the collected discharge.
- Positive whiff test: A few drops of a 10% potassium hydroxide solution are added to a sample of your discharge on a glass slide. If BV is present, the solution releases compounds called amines that produce a distinct fishy smell. Some people notice this odor even without the test, especially after sex.
- Clue cells on microscopy: Under a microscope, your provider looks at your vaginal cells on a wet-mount slide. Clue cells are normal vaginal skin cells that have become so heavily coated with bacteria that their edges look blurred or stippled. For BV to be confirmed through this criterion, more than 20% of the visible skin cells need to be clue cells.
Of these four, clue cells are considered the single most reliable indicator. If your provider sees them under the microscope, BV is very likely even before the other criteria are checked.
The Lab Gold Standard
When a more precise answer is needed, or for research purposes, labs use a method called the Nugent score. This involves staining a vaginal sample and examining it under a microscope to count the relative amounts of different bacterial shapes: the long rods of healthy lactobacilli versus the smaller rods and curved bacteria associated with BV.
The score runs from 0 to 10. A score of 0 to 3 means your vaginal bacteria are predominantly the healthy, protective type. A score of 4 to 6 falls into an intermediate zone where harmful bacteria are starting to emerge but haven’t fully taken over. A score of 7 to 10 confirms BV. The CDC considers this Gram stain method the reference standard for laboratory diagnosis, though many clinics rely on the faster Amsel criteria instead because the results are available immediately.
Molecular Testing
Newer DNA-based tests can identify the specific bacteria involved in BV with high accuracy. One FDA-cleared option, the BD MAX Vaginal Panel, uses PCR technology to detect DNA from multiple organisms in a single vaginal swab. It looks for the presence and relative levels of protective lactobacilli alongside BV-associated bacteria like Gardnerella vaginalis, Atopobium vaginae, and others. The same swab can simultaneously check for yeast infections and trichomoniasis, which is useful because these three conditions have overlapping symptoms.
These molecular tests are more expensive than a simple wet mount, but they’re increasingly available in clinics and through at-home collection kits that you mail to a lab. They’re particularly helpful when symptoms keep coming back or when microscopy results are unclear.
How BV Looks Different From Other Infections
One of the main reasons diagnosis involves multiple tests is that vaginal infections can mimic each other. Knowing how they differ helps you describe your symptoms more accurately to your provider.
BV produces a thin, grayish discharge with a fishy odor, but typically no itching, burning, or visible redness. The vaginal walls look normal on exam, with no inflammation. A yeast infection, by contrast, causes thick, white, clumpy discharge (often described as cottage cheese-like) with intense vulvar itching and visible swelling, but no odor. Trichomoniasis, a sexually transmitted infection, tends to produce a green or yellow frothy discharge with a foul smell, along with vaginal soreness and visible inflammation. In some trichomoniasis cases, the cervix develops a spotted, reddish appearance sometimes called a “strawberry cervix.”
The absence of inflammation is one of BV’s distinguishing features. If your main complaint is itching and irritation rather than odor, BV is less likely to be the cause.
Why pH Alone Isn’t Enough
You can buy vaginal pH test strips at most pharmacies, and a reading above 4.5 can be a useful clue that something is off. But pH alone can’t tell you what’s wrong. Trichomoniasis also raises vaginal pH. So does menstrual blood, recent intercourse, and the hormonal changes around menopause. A high pH reading tells you your vaginal environment has shifted, but it doesn’t distinguish between BV and other possible causes. That’s why diagnosis requires layering pH results with the other clinical criteria or a lab test.
What to Know Before Your Appointment
A few things can interfere with test accuracy. Douching, vaginal medications, and recent intercourse can all alter pH readings and make it harder to spot clue cells. If you’re planning to get tested, avoiding these for 24 to 48 hours beforehand gives the clearest results. Menstrual blood also raises vaginal pH, so testing mid-cycle tends to be more reliable than testing right before or during your period.
If you’ve had BV before and recognize the symptoms, let your provider know. Recurrent BV, defined as three or more episodes in a year, sometimes calls for more thorough testing, including molecular panels, to identify which specific bacteria are driving the imbalance and guide more targeted treatment.